158
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Development and evaluation of Chrysin-Phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity

, &
Pages 600-617 | Received 09 Jul 2018, Accepted 11 Dec 2018, Published online: 22 Feb 2019
 

Abstract

Context: Flavonoids show promising anticancer potential but it is limited due to poor solubility. Objective: The present investigation was to prepare Chrysin-Phospholipid complex loaded solid lipid nanoparticles (Ch-PC-SLNs) for improving its encapsulation as compared to that of Chrysin loaded SLNs (Ch-SLNs) and evaluated for potential increase in the anti-cancer activity against MCF-7 cell line. Methods: The physiochemical characteristics and release kinetics for Ch-SLNs and Ch-PC-SLNs were evaluated and compared. Storage stability of Ch-PC-SLNs was evaluated up to 3 months. Solid state properties (DSC, XRD) and morphology (AFM) of Ch-PC-SLNs were also studied. In-vitro anticancer activity was investigated by using MTT assay. Results and Discussion: Ch-PC-SLNs exhibited higher encapsulation efficiency than Ch-SLNs and zero order release kinetics. Ch-PC-SLNs were found to be stable upto 3 months upon lyophilisation with mannitol as cryoprotectant. DSC and XRD study revealed the loss of highly crystalline nature of Chrysin in Ch-PC-SLNs. The Ch-PC-SLNs lead to significantly higher in-vitro anticancer activity than that of bulk Chrysin. Conclusion: The study concludes that phospholipids complex with Chrysin lead to improve encapsulation, storage stability of SLNs and in vitro anticancer activity.

Acknowledgements

The authors gratefully acknowledge the Director, CSIR-CDRI, Lucknow for providing required facilities. Authors are also thankful to Dr. P.R Mishra, Division of Pharmaceutics, CSIR CDRI, Lucknow for using the AFM facility. Authors also acknowledge the SAIF, Panjab University Chandigarh to perform SEM and X-Ray Diffraction studies of the samples.

Disclosure statement

The authors declare that they have no conflicts of interest.

Additional information

Funding

The authors thank Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India for providing financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.